Atrial fibrillation during the blanking period post ablation correlates with long-term recurrence: myth vs reality
暂无分享,去创建一个
[1] F. Gaita,et al. Evidence-based insights on ideal blanking period duration following atrial fibrillation catheter ablation. , 2022, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[2] U. Schotten,et al. Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillation , 2022, Heart.
[3] D. Lin,et al. Impact of atrial fibrillation recurrences during the blanking period following catheter ablation on long-term arrhythmia-free survival: a prospective study with continuous monitoring , 2022, Journal of Interventional Cardiac Electrophysiology.
[4] W. Shimizu,et al. The association between late-phase early recurrence within the blanking period after atrial fibrillation catheter ablation and long-term recurrence: Insights from a large-scale multicenter study. , 2021, International journal of cardiology.
[5] R. Coronel,et al. The Blinding Period Following Ablation Therapy for Atrial Fibrillation: Proarrhythmic and Antiarrhythmic Pathophysiological Mechanisms. , 2021, JACC. Clinical electrophysiology.
[6] K. Kuck,et al. Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST) , 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[7] H. Calkins,et al. Predictive value of atrial fibrillation during the post radiofrequency ablation blanking period. , 2020, Heart rhythm.
[8] A. Verma,et al. Redefining the Blanking Period After Catheter Ablation for Paroxysmal Atrial Fibrillation: Insights From the ADVICE (Adenosine Following Pulmonary Vein Isolation to Target Dormant Conduction Elimination) Trial , 2016, Circulation. Arrhythmia and electrophysiology.